Leveraging pathogen sequence and contact tracing data to enhance vaccine trials in emerging epidemics. Author(s): Kahn R, Wang R, Leavitt SV, Hanage WP, Lipsitch M|Journal: Epidemiology|PMID: 34039898| May 2021 Advance planning of vaccine trials conducted during outbreaks increases our ability to rapidly define the efficacy and potential impact of…
Analyzing Vaccine Trials in Epidemics with Mild and Asymptomatic Infection. Author(s): Kahn R, Hitchings M, Wang R, Bellan S, Lipsitch M|Journal: Am J Epidemiol|PMID: 30329134| October 2018 Vaccine efficacy against susceptibility to infection (VES), regardless of symptoms, is an important endpoint of vaccine trials for pathogens with…
Competing Effects Of Indirect Protection And Clustering On The Power Of Cluster-Randomized Controlled Vaccine Trials. Author(s): Hitchings MDT, Lipsitch M, Wang R, Bellan SE|Journal: Am J Epidemiol|PMID: 29522080| March 2018
